Nintenib 100 Capsule
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Nintedanib (100mg)
Overview Nintenib 100 Capsule
Nintedanib 100mg capsules treat idiopathic pulmonary fibrosis and non-small cell lung cancer by inhibiting specific cellular pathways crucial to disease progression, thus hindering cancer cell proliferation. Optimal absorption requires taking this medication with food, consistently at the same time daily. Dosage and frequency, determined by your physician based on your condition, may adjust over time; strict adherence to the prescribed regimen is vital to avoid severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue use only under your doctor's guidance. Diarrhea is a prevalent side effect; increased fluid intake is advised, and persistent symptoms warrant medical attention. Further common side effects include nausea, stomach pain, vomiting, abnormal liver enzyme levels, appetite loss, headache, weight loss, and hypertension. Liver function monitoring via blood tests may be necessary. Prior to commencing treatment, disclose any bleeding disorders, hepatic or renal impairment, or concurrent medications, especially anti-infectives, to your physician. Numerous drug interactions are possible; inform your healthcare provider of all medications you're taking. This medication is contraindicated during pregnancy and lactation; reliable contraception for both partners is essential throughout treatment.
Uses of Nintenib 100 Capsule
Managing idiopathic pulmonary fibrosis and non-small cell lung cancer.
Major Benefits of Nintenib 100 Capsule:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Consume Nintenib 100 Capsule with a meal.
Common Side effects of Nintenib 100 Capsule:
- Diarrhea
- Nausea
- Abdominal pain
- Vomiting
- Abnormal liver function tests
- Loss of appetite
- Headache
- Weight loss
- High blood pressure
How to use Nintenib 100 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Nintenib 100 Capsule with food.
How Nintenib 100 Capsule works:
Nintedanib 100mg capsules are an anticancer drug that inhibits the activity of aberrant proteins responsible for stimulating cancer cell proliferation. Simultaneously, it interferes with bodily processes leading to fibrosis—the excessive accumulation of connective tissue—thus hindering or retarding cancerous growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Nintenib 100 Capsule may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Nintenib 100 Capsules is contraindicated during pregnancy due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might consider prescribing it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Nintenib 100 Capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Nintenib 100 Capsule may induce side effects that impair driving ability. Nausea is a potential post-ingestion effect, potentially impacting safe driving.
KidneyCAUTION
Patients with severe kidney impairment should use Nintenib 100mg capsules cautiously, as dosage modification may be necessary. Seek medical advice; data on Nintenib 100mg capsule use in this patient population is scarce.
LiverCAUTION
Patients with liver impairment should use Nintenib 100mg capsules cautiously, potentially requiring dosage modification. Medical advice is essential. Nintenib 100mg capsules are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Nintenib 100 Capsule :
Omit any missed dose of Nintenib 100 Capsule and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Nintenib 100 Capsule
| Label | Value |
|---|---|
| Chemical Category | Indole-2-carboxylic acids |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Behavior Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently